Patents by Inventor Violetta Dimitriadou

Violetta Dimitriadou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123036
    Abstract: This application is directed to methods of treating Graft versus Host Disease (GvHD), specifically acute GvHD and acute gastrointestinal GvHD, using apraglutide.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 18, 2024
    Inventors: Violetta DIMITRIADOU, Nader N. YOUSSEF
  • Publication number: 20220233645
    Abstract: This application is directed to methods of treating Graft versus Host Disease (GvHD), specifically acute GvHD and acute gastrointestinal GvHD, using apraglutide.
    Type: Application
    Filed: January 28, 2022
    Publication date: July 28, 2022
    Inventors: Violetta DIMITRIADOU, Nader N. YOUSSEF
  • Patent number: 7358241
    Abstract: This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms using the farnesylated dibenzodiazepinone compound of Formula I.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: April 15, 2008
    Assignee: Thallion Pharmaceuticals, Inc.
    Inventors: Pierre Falardeau, Francois Berger, Henriette Gourdeau, James B. McAlpine, Chris M. Farnet, Violetta Dimitriadou
  • Patent number: 7186713
    Abstract: This invention relates to methods of inhibiting growth of a cancer cell and methods of treating cancer using a novel farnesylated dibenzodiazepinone.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: March 6, 2007
    Assignee: Ecopia BioSciences, Inc.
    Inventors: Chris M. Farnet, Violetta Dimitriadou, Brian O. Bachmann
  • Publication number: 20060079508
    Abstract: This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms using the farnesylated dibenzodiazepinone compound of Formula I.
    Type: Application
    Filed: May 16, 2005
    Publication date: April 13, 2006
    Inventors: Pierre Falardeau, Francois Berger, Henriette Gourdeau, James McAlpine, Chris Farnet, Violetta Dimitriadou
  • Publication number: 20050107363
    Abstract: This invention relates to methods of inhibiting growth of a cancer cell and methods of treating cancer using a novel farnesylated dibenzodiazepinone.
    Type: Application
    Filed: September 27, 2004
    Publication date: May 19, 2005
    Inventors: Chris Farnet, Violetta Dimitriadou, Brian Bachmann
  • Publication number: 20030100089
    Abstract: A composition comprising a protein having an inhibitory activity for a serine protease and, in particular, for a serine elastase, the protein having a molecular weight of about 46 kDa in a deglycosylated form, and having a molecular weight of about 54 kDa when isolated in a glycosylated form is provided. Methods of using the protein in treatments of diseases where inhibition of a serine protease and, in particular, of a serine elastase is effective are provided as well as compositions, reagents, and kits related thereto.
    Type: Application
    Filed: August 27, 2002
    Publication date: May 29, 2003
    Inventors: Eric Dupont, Richard Beliveau, Denis Gingras, Alain Renaud, France Cadoret, Violetta Dimitriadou, Pierre Falardeau
  • Publication number: 20030087830
    Abstract: Low molecular weight components extracted from shark cartilage and complexes made of copper with amino acid or dipeptide units or analogs thereof are disclosed. Methods are disclosed for the inhibition of angiogenesis (neovascularization) in an animal through the administration of these complexes, which results in treating angiogenesis-dependent diseases.
    Type: Application
    Filed: June 12, 2001
    Publication date: May 8, 2003
    Inventors: Eric Dupont, Denis Lessard, Serge Auger, Violetta Dimitriadou, Pierre Falardeau, Patrick Poyet